Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Primaquine phosphate (substance) |
Is a |
False |
Primaquine (substance) |
Inferred relationship |
Some |
|
Product containing primaquine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Accidental primaquine overdose |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Intentional primaquine overdose |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine overdose |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine overdose of undetermined intent |
Causative agent (attribute) |
False |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely primaquine 7.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Primaquine (substance) |
Inferred relationship |
Some |
|
Primaquine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Poisoning by primaquine |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Allergy to primaquine (finding) |
Causative agent (attribute) |
False |
Primaquine (substance) |
Inferred relationship |
Some |
|
Accidental primaquine poisoning |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Intentional primaquine poisoning |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Allergy to primaquine (finding) |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Product containing primaquine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely primaquine 7.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely primaquine 7.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely primaquine (as primaquine phosphate) 26.3 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
|
Product containing precisely primaquine 7.5 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Product containing only primaquine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine (as primaquine phosphate) 7.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |
Primaquine sensitivity anaemia |
Causative agent (attribute) |
True |
Primaquine (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely primaquine (as primaquine phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Primaquine (substance) |
Inferred relationship |
Some |
1 |